Insider Trades
| Name | Value | Action | Price | Current Price |
|---|---|---|---|---|
Gobel DavidDirector $7.3k3.3k shares SellNov 17, 2025 $2.24 -- | ||||
News
globenewswire.comVivoSim Platform Predicts Gastrointestinal Toxicity (Diarrhea) in an AI Model Trained on Human Intestinal Model Results – Without Animal Testingglobenewswire.comApr 28
defenseworld.netShort Interest in VivoSim Labs, Inc. (NASDAQ:VIVS) Decreases By 69.3%defenseworld.netApr 27
globenewswire.comVivoSim Announces Pricing of up to a $4 Million Public Offeringglobenewswire.comApr 1
defenseworld.netHead-To-Head Analysis: Agenus (NASDAQ:AGEN) and VivoSim Labs (NASDAQ:VIVS)defenseworld.netMar 27
globenewswire.comVivoSim Releases Antibody Drug Conjugate (ADC) Data Showing Power to Detect ADC Toxicity and Guide Design of Safer ADCsglobenewswire.comMar 24